CLCA2 and heart failure: It is therefore imperative for future investigators to focus on delineating the mode of action for Clca2 in the process of FMyT so that the plethora of data, including the ones presented here, can be exploited in the development of novel therapeutic solutions to treat adverse cardiac remodeling and heart failure.